14/04/2026
New research overturns a long standing assumption about cancer surgery and immune defense. For decades, surgeons often removed lymph nodes near a tumor to prevent cancer from spreading. Lymph nodes are small, bean shaped organs scattered throughout the body that filter lymph fluid and house immune cells. Two recent studies found that lymph nodes do far more than passively host immune cells. They actively train and multiply stem like T cells, the specialized white blood cells that seek out and kill cancer cells throughout the body. These stem like cells act as a continuous supply line, feeding fresh cancer fighting soldiers into the bloodstream while tumor resident T cells often become exhausted and ineffective.
When lymph nodes are removed during surgery, this supply and development system is disrupted. The result may be fewer effective T cells entering the tumor, and a weaker response to treatments like checkpoint inhibitors or CAR T cell therapy that rely on a robust immune reaction. Instead of merely filtering fluids, lymph nodes serve as active command centers where dendritic cells present danger signals and nurture T cells into effective immune fighters.
These findings shift how scientists and clinicians think about cancer immunotherapy. Protecting lymph nodes during treatment could boost patient responses and improve long term outcomes by preserving the body’s natural ability to generate potent anti cancer T cells.
Research Paper 📄
DOI: 10.1038/s41590-025-02219-2 ,
DOI: 10.1038/s41590-025-02276-7